Evolving treatment paradigms in recurrent and metastatic head and neck squamous cell carcinoma: the emergence of immunotherapy

被引：1
|
作者：
Faraji, Farhoud [1 ]
Cohen, Ezra E. W. [2 ]
Guo, Theresa W. [1 ]
机构：
[1] UC San Diego Hlth, Gleiberman Head & Neck Canc Ctr, Moores Canc Ctr, Dept Otolaryngol Head & Neck Surg, La Jolla, CA USA
[2] UC San Diego Hlth, Dept Internal Med, Gleiberman Head & Neck Canc Ctr, Moores Canc Ctr,Div Hematol Oncol, La Jolla, CA USA
来源：
TRANSLATIONAL CANCER RESEARCH | 2023年 / 12卷 / 05期
关键词：
Immunotherapy; salvage surgery; head and neck squamous cell carcinoma (HNSCC); HUMAN-PAPILLOMAVIRUS; INVESTIGATORS CHOICE; COMORBIDITY INDEX; MUTATIONAL BURDEN; SURGICAL SALVAGE; PD-1; BLOCKADE; CHECKMATE; 141; OPEN-LABEL; SURVIVAL; CANCER;
D O I：
10.21037/tcr-23-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1353 / 1358
页数：6
相关论文
共 50 条
  • [41] Immunotherapy for Head and Neck Squamous Cell Carcinoma
    Moskovitz, Jessica
    Moy, Jennifer
    Ferris, Robert L.
    CURRENT ONCOLOGY REPORTS, 2018, 20 (02)
  • [42] Immunotherapy for Head and Neck Squamous Cell Carcinoma
    Schoppy, David W.
    Sunwoo, John B.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2015, 29 (06) : 1033 - +
  • [43] Immunotherapy for Head and Neck Squamous Cell Carcinoma
    Jessica Moskovitz
    Jennifer Moy
    Robert L. Ferris
    Current Oncology Reports, 2018, 20
  • [44] Immunotherapy for Head and Neck Squamous Cell Carcinoma
    Hoesli R.C.
    Moyer J.S.
    Current Oral Health Reports, 2016, 3 (2) : 74 - 81
  • [45] Immunotherapy for squamous cell carcinoma of the head and neck
    Yokota, Tomoya
    Homma, Akihiro
    Kiyota, Naomi
    Tahara, Makoto
    Hanai, Nobuhiro
    Asakage, Takahiro
    Matsuura, Kazuto
    Ogawa, Takenori
    Saito, Yuki
    Sano, Daisuke
    Kodaira, Takeshi
    Motegi, Atsushi
    Yasuda, Koichi
    Takahashi, Shunji
    Tanaka, Kaoru
    Onoe, Takuma
    Okano, Susumu
    Imamura, Yoshinori
    Ariizumi, Yosuke
    Hayashi, Ryuichi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (10) : 1089 - 1096
  • [46] Combination treatment of arsenic trioxide and osimertinib in recurrent and metastatic head and neck squamous cell carcinoma
    Hsieh, Ching-Yun
    Chang, Wei-Chao
    Lin, Ching-Chan
    Chen, Jong-Hang
    Lin, Chen-Yuan
    Liu, Chia-Hua
    Lin, Chen
    Hung, Mien-Chie
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (11): : 5049 - +
  • [47] The impact of patient preference in the treatment algorithm for recurrent/metastatic head and neck squamous cell carcinoma
    Viola Salvestrini
    Carlotta Becherini
    Isacco Desideri
    Luisa Caprara
    Matteo Mariotti
    Marco Banini
    Nicola Pierossi
    Vieri Scotti
    Lorenzo Livi
    Pierluigi Bonomo
    La radiologia medica, 2022, 127 : 866 - 871
  • [48] Treatment patterns and outcomes among patients with recurrent/metastatic squamous cell carcinoma of the head and neck
    Nadler, Eric
    Joo, Seongjung
    Boyd, Marley
    Black-Shinn, Jenny
    Chirovsky, Diana
    FUTURE ONCOLOGY, 2019, 15 (07) : 739 - 752
  • [49] The impact of patient preference in the treatment algorithm for recurrent/metastatic head and neck squamous cell carcinoma
    Salvestrini, Viola
    Becherini, Carlotta
    Desideri, Isacco
    Caprara, Luisa
    Mariotti, Matteo
    Banini, Marco
    Pierossi, Nicola
    Scotti, Vieri
    Livi, Lorenzo
    Bonomo, Pierluigi
    RADIOLOGIA MEDICA, 2022, 127 (08): : 866 - 871
  • [50] Evidence-Based Treatment Options in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck
    Argiris, Athanassios
    Harrington, Kevin J.
    Tahara, Makoto
    Schulten, Jeltje
    Chomette, Pauline
    Castro, Ana Ferreira
    Licitra, Lisa
    FRONTIERS IN ONCOLOGY, 2017, 7
12345